The Clinical Trial Burden Calculator, 3 Downsides To DCTs, and More
Clinical Leader
A resource and forum to investigate and resolve the common struggles related to running effective clinical trials.
Welcome to the Clinical Trial Insights newsletter, featuring strategic insights and expert opinions on designing and running clinical trials. Each edition covers the latest trending articles on ClinicalLeader.com.
In this week's issue, we'll explore the industry's first open access financial burden calculator, why it's important to invest in compliance, the downsides of DCTs, tips for a successful digital transformation, and other popular insights.
If you like what you're seeing in our condensed LinkedIn editions, subscribe to our daily newsletter for full access to exclusive articles, webinars, e-books, and more! Subscribe Now →
This Week!
Clinical Leader Solutions Expo: EDC Supplier Showcase
January 31st @ 10AM EST
Join us this week at the Clinical Leader Solutions Expo, where industry-leading EDC providers will present their expertise and capabilities in an interactive forum designed to inform and connect your trial needs with solutions.
TOP 5 READS OF THE PAST WEEK
Larry Ajuwon shares how TrialValueapp developed the industry’s first open access financial burden calculator to help patients, sponsors, and other stakeholders estimate the cost burden patients may face under applicable scenarios.
In the highly regulated world of clinical research, compliance is an ongoing concern, but can be viewed as an annoying and costly item to check off a regulatory to-do list. Pro-ficiency (a Simulations Plus company) 's Robin Newman, MSN EdD CPNP explains why a front-loaded investment in compliance can be instrumental in sustaining the integrity of the research process.
Recommended by LinkedIn
DCTs offer several potential benefits. However, the industry should be thoughtful as it embraces decentralization. James Gillespie and Gregory Privitera discuss three overlapping categories of concern when it comes to DCTs: consent and selection, user experience, and comfort and privacy.
While regulatory bodies still accept PRO data collected on paper, the quality and integrity of such data are increasingly scrutinized. Signant Health provides real-world examples of how electronic patient-reported outcome measures (PROMs) optimize data quality and reliability and improve the statistical power of trial data.
Despite the digital “revolution” being more than 70 years old, digital transformation continues and mistakes are still being made. But that does not need to be the case! In this Clinical Tech Leader article, L. Allen Kindman MD outlines some of the problems he has seen over several decades of digital transformations and provides tips for success.
MORE TO EXPLORE
Clinical Leader is an online community serving professionals in the clinical research space. We share insights and best practices — from industry experts — to help sponsors and CROs tackle the biggest challenges they face in designing and running clinical trials.
To get the most out of our offerings, join the Clinical Leader community.